Research ProgramsDisease-based ProgramsKidney CancerGrants and Funding
Grants and Funding
Kidney Cancer Specific Support | Principal
Investigator | Role on Projects and Cores | Sponsor/Type | Title | Funding Period | Atkins | SPORE Director Project 3 Co-PI Core 1 Director | NIH/P50 CA101942
| DF/HCC Renal Cancer SPORE | 09/18/03-06/30/09 | Bardeesy | Project 1 Co-Investigator | Alex’s Lemonade Stand Foundation for Childhood Cancer | A mouse model of Wilms Tumor | 07/01/08-06/30/10 | Bhatt | Project 3 Co-Investigator | VHL Family <city w:st="on"><place w:st="on">Alliance</place></city> | Role of the Interferon Gamma Pathway in Resistance to Antiangiogenic Therapy | 08/01/08-07/31/09 | Haber | Project 1 Co-PI | NIH/R37 CA58596 | Functional Properties of the Wilms Tumor Gene WT1 (MERIT Award) | 01/01/93-12/31/11 | Iliopoulos | SPORE-Co-PI Core 1, 3, Co-PI DRP Co-PI | NIH/R01 CA104574 | Molecular targets of hypoxia signaling in cancer | 07/09/04-04/30/09 | Kaelin | SpORE Co-PI Core 1 Co-PI Project 2 Co-PI CDA Co-PI | Howard Hughes Medical Institute
NIH/R01 CA68490
Doris Duke Charitable Foundation | Functional Analysis of Novel Tumor Suppressor Proteins
Functional Analysis of the von Hippel-Lindau Protein
Translational Studies Based on Tumor Suppressor Proteins | 02/02/98-08/31/12
09/27/06-05/31/11
01/01/07-12/31/11
| Rivera | Project 1 Co-PI | K08 DK080175
Burroughs Wellcome Fund Career Awards for Medical Scientists | Functional Characterization of WTX in Renal Development
Characterization of a novel X-linked tumor suppressor, WTX, in pediatric cancer | 09/30/07-08/31/12
09/01/08-08/31/13
|
|
|